David J. Kittlesen

Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation

David J. Kittlesen, Kimberly A. Chianese‐Bullock, Zhi Q. Yao et al. · Journal of Clinical Investigation · 2000 · 328 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Suppression of Host Immune Response by the Core Protein of Hepatitis C Virus: Possible Implications for Hepatitis C Virus Persistence

Mary Kathryn Large, David J. Kittlesen, Young S. Hahn · The Journal of Immunology · 1999 · 257 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes.

Craig L. Slingluff, Galina V. Yamshchikov, Patrice Y. Neese et al. · PubMed · 2001 · 229 citations

Medicine, Immunology, Oncology +17

Human Melanoma Patients Recognize an HLA-A1-Restricted CTL Epitope from Tyrosinase Containing Two Cysteine Residues: Implications for Tumor Vaccine Development

David J. Kittlesen, Lee W. Thompson, Pamela H. Gulden et al. · The Journal of Immunology · 1998 · 135 citations · Full text

Life Sciences, Immunology, Oncology +17

The Class I Antigen-processing Pathway for the Membrane Protein Tyrosinase Involves Translation in the Endoplasmic Reticulum and Processing in the Cytosol

Claudio A. Mosse, Leslie Meadows, Chance John Luckey et al. · The Journal of Experimental Medicine · 1998 · 121 citations · Full text

Life Sciences, Immunology, Molecular Biology +17